|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 61 | 2018 | Hepatitis C Nurse As a Case Manager in People Who Inject Drugs | BIELEN, Rob; DERCON, Eefje; KOC, Ozgur; BUSSCHOTS, Dana; Vinken, Lou; Verrando, Rita; VANHEES, Kimberly; Nevens, Frederik; ROBAEYS, Geert | Journal Contribution | M |
| 62 | 2018 | The Prevalence and Risk Factors of Hepatitis B Viral Infection in Middle Limburg Belgium: The Importance of Migration. | KOC, Ozgur; KREMER, Cécile; BIELEN, Rob; BUSSCHOTS, Dana; HENS, Niel; ROBAEYS, Geert | Journal Contribution | M |
| 103 | 2018 | Horizontal hepatitis B virus transmission through non-sexual close contact in Turkish chronic hepatitis B patients living outside of Turkey. | KOC, Ozgur; ROBAEYS, Geert; Yildirim, B.; Posthouwer, D.; HENS, Niel; Koek, GH. | Journal Contribution | A1 |
| 104 | 2018 | An adult patient with alcoholic liver cirrhosis and IgA vasculitis | Barrios, Leticia; ROBAEYS, Geert | Journal Contribution | A1 |
| 105 | 2018 | Screening for hepatitis C at the emergency department: Should babyboomers also be screened in Belgium? | BIELEN, Rob; KREMER, Cécile; KOC, Ozgur; BUSSCHOTS, Dana; HENDRICKX, Diana; VANELDEREN, Pascal; HENS, Niel; Nevens, Frederik; ROBAEYS, Geert | Journal Contribution | A1 |
| 86 | 2018 | Pneumomediastinum as a complication of esophageal intramural pseudodiverticulosis | Struyve, M.; Langmans, C.; ROBAEYS, Geert | Journal Contribution | A1 |
| 87 | 2018 | Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes | Van Hees, S.; Bourgeois, S.; Van Vlierberghe, Hans; Serste, T.; Francque, S.; Michielsen, P.; Sprengers, D.; Reynaert, H.; Henrion, J.; Dastis, S. Negrin; Delwaide, J.; Lasser, L.; Decaestecker, J.; Orlent, H.; Janssens, F.; ROBAEYS, Geert; Colle, I.; Starkel, P.; Moreno, C.; Nevens, F.; Vanwolleghem, T. | Journal Contribution | A1 |
| 88 | 2018 | The burden of viral hepatitis C in key subgroups in Belgium: targets for micro-elimination | BIELEN, Rob; Salomonsson, S.; Toghanian, S.; VENKEN, Koen; Hiver, M.; Matthys, A.; Hendrickx, G.; Jadoul, M.; Nevens, F.; ROBAEYS, Geert; Lazarus, J. V. | Journal Contribution | M |
| 89 | 2018 | Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe | Marshall, Alison D.; Cunningham, Evan B.; Nielsen, Stine; Aghemo, Alessio; Alho, Hannu; Backmund, Markus; Bruggmann, Philip; Dalgard, Olav; Seguin-Devaux, Carole; Flisiak, Robert; Foster, Graham R.; Gheorghe, Liana; Goldberg, David; Goulis, Ioannis; Hickman, Matthew; Hoffmann, Patrick; Jancoriene, Ligita; Jarcuska, Peter; Kaberg, Martin; Kostrikis, Leondios G.; Makara, Mihaly; Maimets, Matti; Marinho, Rui Tato; Maticic, Mojca; Norris, Suzanne; Olafsson, Sigurour; Ovrehus, Anne; Pawlotsky, Jean-Michel; Pocock, James; ROBAEYS, Geert; Roncero, Carlos; Simonova, Marieta; Sperl, Jan; Tait, Michele; Tolmane, Ieva; Tomaselli, Stefan; van der Valk, Marc; Vince, Adriana; Dore, Gregory J.; Lazarus, Jeffrey V.; Grebely, Jason | Journal Contribution | A1 |
| 90 | 2017 | Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogues is highly effective and reduces cost for hepatitis B prophylaxis after liver transplantation | BIELEN, Rob; ROBAEYS, Geert; Schelfhout, S.; Monbaliu, D.; Van der Merwe, S.; Pirenne, J.; Nevens, F. | Journal Contribution | M |
| 91 | 2017 | Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs | Grebely, Jason; Bruneau, Julie; Lazarus, Jeffrey V.; Dalgard, Olav; Bruggmann, Philip; Treloar, Carla; Hickman, Matthew; Hellard, Margaret; Roberts, Teri; Crooks, Levinia; Midgard, Havard; Larney, Sarah; Degenhardt, Louisa; Alho, Hannu; Byrne, Jude; Dillon, John F.; Feld, Jordan J.; Foster, Graham; Goldberg, David; Lloyd, Andrew R.; Reimer, Jens; ROBAEYS, Geert; Torrens, Marta; Wright, Nat; Maremmani, Icro; Norton, Brianna L.; Litwin, Alain H.; Dore, Gregory J. | Journal Contribution | A1 |
| 92 | 2017 | Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study | Grebely, Jason; Dalgard, Olav; Cunningham, Evan B.; Hajarizadeh, Behzad; Foster, Graham R.; Bruggmann, Philip; Conway, Brian; Backmund, Markus; ROBAEYS, Geert; Swan, Tracy; Amin, Janaki; Marks, Philippa S.; Quiene, Sophie; Applegate, Tanya L.; Weltman, Martin; Shaw, David; Dunlop, Adrian; Hellard, Margaret; Bruneau, Julie; Midgard, Havard; Bourgeois, Stefan; Staehelin, Cornelia; Dore, Gregory J. | Journal Contribution | A1 |
| 93 | 2017 | Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogues is highly effective and reduces cost for hepatitis B prophylaxis after liver transplantation | BIELEN, Rob; ROBAEYS, Geert; Schelfhout, S.; Monbaliu, D.; Van Der Merwe, S.; Pirenne, J.; Nevens, F. | Conference Material | C2 |
| 94 | 2017 | The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without pegylated interferon: a Belgian experience | BIELEN, Rob; Moreno, C.; Van Vlierberghe, H.; Bourgeois, S.; Mulkay, J. -P.; Francque, S.; Verlinden, W.; Brixko, C.; Decaestecker, J.; De Galocsy, C.; Janssens, F.; Cool, M.; Van Steenkiste, C.; D'heygere, F.; Wuyckens, K.; Nevens, F.; ROBAEYS, Geert | Journal Contribution | M |
| 95 | 2017 | Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe | Marshall, A. D.; Nielsen, S.; Cunningham, E. B.; Aghemo, A.; Alho, H.; Backmund, M.; Bruggmann, P.; Dalgard, O.; Flisiak, R.; Foster, G.; Gheorghe, L.; Goldberg, D.; Goulis, I.; Hickman, M.; Hoffmann, P.; Jancoriene, L.; Jarcuska, P.; Kaberg, M.; Makara, M.; Maimets, M.; Marinho, R.; Maticic, M.; Norris, S.; Olafsson, S.; Ovrehus, A.; Pawlotsky, J. -M.; Pocock, J.; ROBAEYS, Geert; Roncero, C.; Simonova, M.; Sperl, J.; Tait, M.; Tolmane, I.; Tomaselli, S.; van der Valk, M.; Vince, A.; Dore, G. J.; Lazarus, J. V.; Grebely, J. | Journal Contribution | M |
| 96 | 2017 | Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogues is highly effective and reduces cost for hepatitis B prophylaxis after liver transplantation | BIELEN, Rob; ROBAEYS, Geert; Schelfhout, S.; Monbaliu, D.; Van Der Merwe, S.; Pirenne, J. | Conference Material | C2 |
| 97 | 2017 | Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study | Cunningham, Evan B.; Hajarizadeh, Behzad; Dalgard, Olav; Amin, Janaki; Hellard, Margaret; Foster, Graham R.; Bruggmann, Philip; Conway, Brian; Backmund, Markus; ROBAEYS, Geert; Swan, Tracy; Marks, Philippa S.; Quiene, Sophie; Applegate, Tanya L.; Weltman, Martin; Shaw, David; Dunlop, Adrian; Bruneau, Julie; Midgard, Havard; Bourgeois, Stefan; Thurnheer, Maria Christine; Dore, Gregory J.; Grebely, Jason | Journal Contribution | A1 |
| 98 | 2017 | The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C infected patients treated with direct acting antivirals with and without Pegylated Interferon: A Belgian experience. | BIELEN, Rob; Van Vlierberghe, H.; Bourgeois, S.; Moreno, C.; Vanwollegem, T.; Verlinden, W.; Mulkay, J.P.; Decaestecker, J.; Cool, M.; de Galocsy, C.; Van Overbeke, L.; Janssens, F.; Van Steenkiste, C.; Wuyckens, K.; Nevens, F.; ROBAEYS, Geert | Conference Material | C2 |
| 99 | 2017 | Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study | Midgard, Havard; Hajarizadeh, Behzad; Cunningham, Evan B.; Conway, Brian; Backmund, Markus; Bruggmann, Philip; Bruneau, Julie; Bourgeois, Stefan; Dunlop, Adrian; Foster, Graham R.; Hellard, Margaret; ROBAEYS, Geert; Thurnheer, Maria C.; Weltman, Martin; Amin, Janaki; Marks, Philippa S.; Quiene, Sophie; Dore, Gregory J.; Dalgard, Olav; Grebely, Jason | Journal Contribution | A1 |
| 100 | 2017 | Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse | Lamoury, Francois M. J.; Soker, Angelica; Martinez, Danica; Hajarizadeh, Behzad; Cunningham, Evan B.; Cunningham, Philip; Bruggmann, Philip; Foster, Graham R.; Dalgard, Olav; Backmund, Markus; Conway, Brian; ROBAEYS, Geert; Swan, Tracy; Cloherty, Gavin; Marks, Pip; Grebely, Jason; Dore, Gregory J.; Applegate, Tanya L. | Journal Contribution | A1 |
Loading...
5
0
5
0
false